Which hedge funds own DMAC? DIAMEDICA THERAPEUTICS INC, Q2 2026 13F holders
3 of the hedge funds tracked by WhaleCreep disclosed a position in DMAC (DIAMEDICA THERAPEUTICS INC) in their Q2 2026 13F filings, worth $7.1m in total. The largest holder by portfolio weight is Millennium Management at 0.0% of its book. 2 exited: First Manhattan, Renaissance Technologies LLC.
3tracked managers holding
0opened this quarter
2exited this quarter
Which hedge funds hold DMAC? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Millennium Management | Q2 2026 | 0.0% | $6.0m | 845,309 | -10% | reduced |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $127.0k | 18,036 | 27% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $1.0m | 145,870 | 0% | held |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| First Manhattan | 0.6% | $3.1m |
| Renaissance Technologies LLC | 0.0% | $355.6k |
How has hedge fund ownership of DMAC changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 3 | $7.1m |
| Q1 2026 | 5 | $10.9m |
| Q4 2025 | 1 | $3.2m |
| Q3 2025 | 1 | $3.5m |
| Q2 2025 | 1 | $2.4m |
| Q1 2025 | 1 | $2.3m |
| Q4 2024 | 1 | $4.6m |
| Q3 2024 | 1 | $3.5m |
| Q2 2024 | 1 | $2.5m |
| Q1 2024 | 1 | $2.4m |
| Q4 2023 | 1 | $325.9k |
| Q3 2023 | 1 | $296.0k |
| Q2 2023 | 1 | $538.9k |
| Q1 2023 | 1 | $99.0k |
| Q4 2022 | 1 | $53.0k |
| Q2 2021 | 1 | $419.0k |
Counts every tracked manager that disclosed DMAC in that quarter's filing, including managers that have since stopped filing.